Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Instil Bio, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of TIL: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5662+6
Shares65.0M70.4M+5.40M (+8.3%)
Value$1.62B$1.35B−$271.2M (−16.8%)

New holders (27)

Institutions that held Instil Bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to TIL in Q2 2021
InstitutionSharesValue% of portfolio
State Street Corp250,061$4.83M0.00%
UBS Asset Management Americas Inc237,959$4.60M0.00%
Northern Trust Corp188,059$3.63M0.00%
Charles Schwab Investment Management Inc118,435$2.29M0.00%
QVT Financial LP98,644$1.91M0.13%
Vident Investment Advisory, LLC93,230$1.80M0.05%
Nuveen Asset Management, LLC58,434$1.13M0.00%
D. E. Shaw & Co., Inc.42,457$820.0K0.00%
HighVista Strategies LLC41,436$801.0K0.57%
Parametric Portfolio Associates LLC26,970$521.0K0.00%
Legato Capital Management LLC24,393$471.0K0.07%
California State Teachers Retirement System24,054$465.0K0.00%
State of Wisconsin Investment Board17,585$340.0K0.00%
Rhumbline Advisers16,045$310.0K0.00%
Manufacturers Life Insurance Company, The11,268$218.0K0.00%
Deutsche Bank AG10,349$200.0K0.00%
ACT Capital Management, LLC10,000$194.0K0.10%
American International Group, Inc.9,766$189.0K0.00%
MetLife Investment Management8,390$162.1K0.00%
Metropolitan Life Insurance Co6,424$124.1K0.00%
STRS Ohio4,000$77.0K0.00%
Bank of America Corp2,739$53.0K0.00%
Rockefeller Capital Management L.P.1,700$32.0K0.00%
Ameritas Investment Partners, Inc.1,367$26.0K0.00%
Citigroup Inc828$16.0K0.00%
UBS Group AG714$14.0K0.00%
State of Wyoming327$6.00K0.00%

Sold out (21)

Institutions that held Instil Bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.